Rapamycin in Relapsed Acute Lymphoblastic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

April 30, 2016

Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG

Corticosteroid

Initial dose of corticosteroid given intravenously. After the first dose, corticosteroid will be taken orally every 8 hours for the duration of the five-day period

DRUG

Rapamycin

Taken orally mixed with water or orange juice

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00874562 - Rapamycin in Relapsed Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter